NOTE 9 – COMMITMENTS AND CONTINGENCIES The Company has certain financial commitments relating to research and development contracts as of June 30, 2025, as follows: | · | The Company is invoiced monthly and quarterly in connection with several research and development contracts. | | · | The Company may be obligated to make additional payments related to research and development contracts entered into, dependent on the progress and milestones achieved through the programs. | | · | The Company’s principal executive office is currently located at 505 Lomas Santa Fe Drive, Suite 160, Solana Beach, CA, US. Additionally, we have an office outside Manchester, UK, which serves as administrative spaces for managing our subsidiaries, Trinity Reliant Ventures, Ltd (Ireland) and Artelo Biosciences Limited (UK). We do not currently own any properties, laboratories, or manufacturing facilities. The Solana Beach lease runs through August 2027 and the Manchester UK lease is month-to-month. | | · | The Company agreed that $250 of the proceeds of the financing closed June 26, 2025, will be used to purchase SOL. |
|